Select Medical Holdings Corp (SEM) Stock Analysis
Verdict: AVOID
The completed acquisition at $16.50 per share leaves the stock with zero upside and immediate delisting risk.
Investment score: 1/100
Analysis as of
Is Select Medical Holdings Corp stock worth reviewing? The TradeMates thesis
Avoid. The acquisition by a consortium for $16.50 per share was completed on June 30, 2026. The stock is currently trading at $16.51, meaning any new purchase results in a guaranteed loss of $0.01 per share upon settlement of the merger consideration.
7-factor investment score
- Valuation: 0/100 (weight 20%)
- Financial Health: 30/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 0/100 (weight 15%)
Select Medical Holdings Corp opportunities and risks
What speaks for SEM
- Final Cash Distribution
What speaks against SEM
- Negative Arbitrage Gap
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| SEM | 15.1x | 0.4x | 9.7x | 10.6% | 2.4% | 5.7% |
| CON | 23.1x | 1.8x | 14.3x | 27.8% | 8.0% | 7.1% |
| BKD | n/a | 1.2x | 23.3x | 14.3% | -6.6% | 0.2% |
| NHC | 27.5x | 2.2x | 15.7x | 37.2% | 8.1% | 4.9% |
| ACHC | n/a | 0.9x | n/a | 56.2% | -32.8% | -10.0% |
| SGRY | n/a | 0.7x | 6.4x | 21.7% | -2.3% | 9.3% |
| Peer median | n/a | 1.2x | 14.3x | 27.8% | -2.3% | 4.9% |
Frequently asked questions about Select Medical Holdings Corp (SEM)
Is SEM stock a good investment?
The TradeMates model rates Select Medical Holdings Corp as AVOID with an investment score of 1/100. Avoid. The acquisition by a consortium for $16.50 per share was completed on June 30, 2026. The stock is currently trading at $16.51, meaning any new purchase results in a guaranteed loss of $0.01 per share upon settlement of the merger consideration. This is algorithmic model output, not personal investment advice.
Is SEM stock a buy?
The TradeMates model verdict for SEM is AVOID with an investment score of 1/100. Treat this as a model signal to review, not a personal buy recommendation.